{"status": "ok", "totalResults": 5, "articles": [{"source": {"id": null, "name": "Ambcrypto.com"}, "author": "Abiodun Oladokun", "title": "Ethereum price prediction: Why a move to $4K may take time - AMBCrypto News", "description": "Ethereum\u2019s key indicators confirmed that its price has consolidated within a range since 20th May.", "url": "https://ambcrypto.com/ethereum-price-prediction-why-a-move-to-4k-may-take-time/", "urlToImage": "https://ambcrypto.com/wp-content/uploads/2024/06/eth-1000x600.png", "publishedAt": "2024-06-01T22:03:48Z", "content": "<ul><li>Ethereum has trended within a range in the past ten days.</li><li>Futures traders continue to take long positions.</li></ul>An analysis for Ethereum [ETH] price prediction showed that ETH has\u2026 [+2433 chars]"}, {"source": {"id": null, "name": "Financial Times"}, "author": "Ian Johnston", "title": "GSK set to face jury trials over heartburn drug Zantac - Financial Times", "description": "Judge rules experts\u2019 evidence admissible, leaving route open for 72,000 cancer sufferers to bring cases", "url": "https://www.ft.com/content/b5d60754-9635-4909-9481-af02de8d9525", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F534847dd-d7fd-4802-84be-7b83d751c47a.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2024-06-01T14:39:56Z", "content": "GSK and other pharmaceutical groups are set to face jury trials in cases brought by more than 72,000 cancer sufferers who allege a heartburn drug caused their condition, after a judge in Delaware rul\u2026 [+3135 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Financial Times"}, "author": "Christopher Grimes, Anna Nicolaou, James Fontanella-Khan", "title": "Paramount directors support sweetened offer from Ellison's Skydance - Financial Times", "description": "Final decision over Hollywood studio group rests with controlling shareholder Shari Redstone", "url": "https://www.ft.com/content/3d13fadb-6fc5-4a0b-8ed9-833fa50f93ad", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252Fe64c0f8f-7d88-4820-abd7-9aaf2fd07e0c.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2024-05-31T21:35:02Z", "content": "A special committee of Paramount directors has recommended a sweetened acquisition offer from Skydance Media, people briefed on the matter said, leaving the final decision over whether to sell the st\u2026 [+3071 chars]"}, {"source": {"id": null, "name": "Financial Times"}, "author": "Oliver Barnes", "title": "Moderna wins second approval with vaccine targeting RSV infection - Financial Times", "description": "US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab", "url": "https://www.ft.com/content/886c2e86-e5cc-4ade-9810-20d34b013dad", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F95973bf8-22db-456f-a304-770134764865.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2024-05-31T16:43:47Z", "content": "Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step forward in the biotechs efforts to convince investors of its path back to growth after the \u2026 [+2683 chars]"}]}